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(M. Furlan).A reinvestigation of the monoterpene chromane ester enriched fraction from Peperomia obtusifolia using
chiral chromatography led to the identiﬁcation of a minor peak, which was elucidated by NMR and HRMS
as fenchyl-3,4-dihydro-5-hydroxy-2,7-dimethyl-8-(300-methyl-200-butenyl)-2-(40-methyl-10 ,30-pentadie-
nyl)-2H-1-benzopyran-6-carboxylate, the same structure assigned to two other fenchyl esters described
previously, pointing out a stereoisomeric relationship among them. Further NMR analysis revealed that it
was actually a mixture of two compounds, whose absolute conﬁgurations were determined by VCD mea-
surements. Although, almost no vibrational transitions could be assigned to the chiral chromane, the
experimental VCD spectrum was largely opposite to that obtained for the average experimental VCD
[(2S,1000R,2000R,4000S + 2R,1000R,2000R,4000S)/2] for fenchol derivatives. These results allowed us to assign the puta-
tive compounds as a racemic mixture of the chiral chromane esteriﬁed with the monoterpene (1S,2S,4R)-
fenchol, which had not been identiﬁed in our early work.
 2012 Elsevier Ltd. All rights reserved.Introduction
Peperomia obtusifolia (Piperaceae) is a well known foliage plant
which grows from Mexico to South America.1 In spite of its main
ornamental use, some Central American communities utilize this
species to treat insect and snake bites or even as a skin cleanser.2
Previous bioactivity-guided studies resulted in the isolation of
racemic chromanes with potent trypanocidal activity and low
unspeciﬁc cytotoxicity, among other secondary metabolites.3,4
Moreover, a recent report from our research group5 described the
isolation, structure elucidation, and absolute conﬁguration of six
novel isomeric monoterpene chromane esters from P. obtusifolia.
Four compounds esteriﬁed with borneol and two with fenchol
were identiﬁed and their absolute conﬁguration, involving four
chiral centers, was unambiguously determined by using vibra-
tional circular dichroism (VCD) and density functional theory
(DFT) calculations. The ﬁnding of both enantiomers of the bornyl
moiety, but only a sole enantiomeric form of the fenchyl moiety,
that is, 1R,2R,4S, tethered to the chiral chromane prompted us toll rights reserved.
x: +55 16 3301 9692 (J.M.B.);
.
ta), maysaf@reitoria.unesp.brreinvestigate the chiral chromatogram of the chromane ester en-
riched fraction.
As a result, a minor unresolved peak was puriﬁed and eluci-
dated as a novel diastereomeric mixture containing racemic
proportion of the enantiomers of the chiral chromane 3,4-dihy-
dro-5-hydroxy-2,7-dimethyl-8-(300-methyl-200-butenyl)-2-(40-methyl-
10,30-pentadienyl)-2H-1-benzopyran-6-carboxylic acid both esteriﬁed
with the monoterpene (1S,2S,4R)-fenchol, which had not been
identiﬁed in our early work. Therefore, we herein report the capa-
bility of VCD to determine the absolute conﬁguration of complex
natural products even in mixtures and without the aid of further
DFT calculations. Moreover, the isolation of secondary metabolites
with new stereochemical composition opens a new avenue in
understanding the biosynthetic pathways involved in the forma-
tion of monoterpene chromane esters in P. obtusifolia.
Materials and methods
General
NMR spectra were obtained with a Varian INOVA NMR spec-
trometer at 500 MHz for 1H using TMS as chemical shift reference.
The HRESIMS spectra were obtained on a Bruker ultrOTOF-Q-ESI-
TOF Mass Spectrometer. Analytical HPLC analyses were performed
using stainless-steel Phenomenex Lux Cellulose-1 (250  4.6 mm,
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5 lm), Chiralcel OC-H (250  4.6 mm, 5 lm), and Chiralpak IC
(250  4.6 mm, 5 lm) columns. Semi-preparative enantiosepara-
tions were performed using Daicel Chiralcel OD-H column
(250  10 mm, 5 lm). Mobile phase for chromatography was pre-
pared from HPLC grade n-hexane 95%, ethanol, methanol, and ace-
tonitrile purchased from Tedia. Water was puriﬁed in-house with a
Millipore Milli-Q system. HPLC separations were carried out using
a Shimadzu LC-20AT pump system, a SIL-20A auto-sampler, and a
SPD-M20A UV-PDA detector. The IR and VCD spectra were re-
corded with a modiﬁed BioTools Dual-PEM6 ChiralIR™ FT-VCD
spectrometer using a resolution of 4 cm1 and a collection time
of 11 h. The optimum retardation of the two ZnSe photoelastic
modulators (PEMs) was set at 1400 cm1. An optical band-pass ﬁl-
ter was used to allow only the spectral region 800–2000 cm1 to
reach the detector. Spectra were calibrated automatically, using
the standard calibration ﬁles. VCD spectra were recorded in CDCl3
solution (3.0 mg in 100 lL of CDCl3 in a BaF2 cell with 100 lm path
length). Baseline offsets were eliminated by subtracting the VCD
spectrum of the sample from that obtained for the solvent under
identical conditions.
Plant material, extraction, and isolation
Leaves and stems from Peperomia obtusifolia A. Dietr. (Pipera-
ceae) were collected in Araraquara, SP, Brazil, and identiﬁed by
Dr. Inês Cordeiro (Instituto de Botânica, São Paulo, SP, Brazil). The
voucher specimen (KATO 070) was deposited at the Herbário do
Estado ‘Maria Eneyda P. Kaufmann Fidalgo’ (São Paulo, SP, Brazil).
Specimens were cultivated under greenhouse conditions at the
Institute of Chemistry – UNESP in Araraquara, SP, Brazil. The proce-
dure for obtaining the monoterpene chromane ester enriched
fraction was previously described.5 This fraction (2.0 mg/mL in
n-hexane) was then successively subjected to normal phase
semi-preparative chiral HPLC using Chiralcel OD-H column
(250  10 mm; 5 lm) with isocratic elution of 100% n-hexaneFigure 1. Analytical chiral chromatograms of the monoterpene chromane ester enrich
(250  4.6 mm, 5 lm) column, isocratic elution using 100% n-hexane 95%, ﬂow rate of 095% over 30 min at a ﬂow rate of 2.0 mL/min and with injection
volume of 250 lL. The peak eluting at tR = 11.7 min corresponded
to the novel diastereomeric mixture (1).
Results and discussion
The reinvestigation of the monoterpene chromane ester en-
riched fraction using chiral chromatography resulted in the identi-
ﬁcation of a minor peak (1) with shorter retention time when
compared with the other compounds previously isolated (Fig. 1).
Peaks 2 and 3 in the chromatogram presented in Figure 1 corre-
spond to ()-(2S,1000R,2000R,4000S)- and (+)-(2R,1000R,2000R,4000S)-fenchyl-
3,4-dihydro-5-hydroxy-2,7-dimethyl-8-(300-methyl-200-butenyl)-2-
(40-methyl-10,30-pentadienyl)-2H-1-benzopyran-6-carboxylate, respec-
tively, while the unnumbered peaks from 17 to 27 min correspond
to ()-(2S,1000S,2000R,4000S)- and (+)-(2R,1000S,2000R,4000S)-bornyl-3,4-dihy-
dro-5-hydroxy-2,7-dimethyl-8-(300-methyl-200-butenyl)-2-(40-methyl-
10,30-pentadienyl)-2H-1-benzopyran-6-carboxylate along with
their enantiomers. Peak 1 was then further puriﬁed and yielded
an identical UV spectrum and the same HRESIMS ([M+H]+ obsd
m/z 507.3468, Calcd for C33H47O4 m/z 507.3474; [M+Na]+ obsd
m/z 529.3324, Calcd 529.3293) as the six monoterpene chromane
esters recently reported.5 Additionally, the subsequent fragmenta-
tion by MS–MS of the quasi-molecular ion [M+H]+ = 507.3468 gave
rise to the fragment ionsm/z 371.2232 and 353.2133 indicating the
loss of the monoterpene moiety followed by the loss of a water
molecule. The 1H NMR data were compared with literature values
and conﬁrmed the new structure as fenchyl-3,4-dihydro-5-hydro-
xy-2,7-dimethyl-8-(300-methyl-200-butenyl)-2-(40-methyl-10,30-pen-
tadienyl)-2H-1-benzopyran-6-carboxylate (1), the same structure
assigned to the other fenchol derivatives5 described recently,
pointing out a stereoisomeric relationship among them. However,
from the 1H NMR spectrum it was possible to observe some dupli-
cated signals, particularly in the region from 5.4 to 6.3 ppm where
three hydrogen resonances (H-10, H-20, and H-30), which arise from
the diene directly bound to the stereogenic center at C-2, are lo-ed fraction and the novel compound 1. Conditions: Phenomenex Lux Cellulose-1
.8 mL/min, and UV detection at 254 nm.
Figure 2. 1H NMR and 1D NOESY spectra of compound 1.
Figure 3. Observed IR spectrum of 1.
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of compounds rather than a single isomer. Further chromato-
graphic studies using distinct chiral stationary phases were then
carried out in an effort to resolve the putative mixture 1. However,
none of the four different commercial chiral columns employed,
namely, Lux Cellulose-1, Chiralcel OD-RH, Chiralcel OC-H, and
Chiralpak IC, was able to separate it. The analysis of the 1D NOESY
spectrum of 1 demonstrated it to have H-2000 as exo and the
chromane group at the endo side of the fenchyl moiety, the same
relative conﬁguration assigned to the other two fenchyl esters
isolated from P. obtusifolia. Upon irradiation of H-2000, a NOE
enhancement was observed for H-7000 (d 1.14) (Fig. 2).
In order to assess the absolute conﬁguration of 1, IR and VCD
measurements (Figs. 3 and 4) were carried out. From the IR spec-
trum we could see basically the same vibrational transitions
(975, 1040, 1090, 1200, 1275, 1350, 1400, 1450, 1650, and
1725 cm1) as those observed in the unpolarized absorption spec-
tra for the other isomers that corroborate the structure assigned.
From the VCD spectrum, however, almost no vibrational transi-
tions could be assigned to the chiral chromane. Only those transi-
tions previously designated as markers for the monoterpene
stereochemistry were predominantly observed, namely, 975,
1040, and 1090 cm1. More interestingly, the experimental VCD
spectrum of 1was largely opposite to that obtained for the average
experimental VCD [(2S,1000R,2000R,4000S + 2R,1000R,2000R,4000S)/2] for the
fenchol derivatives 2 and 3, respectively, described in our early
work5 (Fig. 4). Compounds 2 and 3 shared the same absolute con-
ﬁguration within the fenchyl moiety, but presented inverted con-
ﬁgurations for the chiral chromane. Upon averaging their
experimental spectra one gets rid of the signals with opposite sign,
which come predominantly from the vibrational transitions of the
enantiomeric chromanes and ends up with a spectrum reﬂecting
most of the transitions of the chiral terpene, despite some over-
lapped normal modes.These results allowed us to assign the structure of 1 as a race-
mic mixture of the chiral chromane esteriﬁed with the monoter-
pene (1S,2S,4R)-fenchol, which had not been described in our
previous work. Additionally, this is the ﬁrst time these two com-
pounds are described in nature. As advocated in our former paper,5
‘due to the presence of fundamentals assigned as markers both for
monoterpene and chromane stereochemistry, the absolute conﬁg-
uration of related molecules could be assessed in the future using
VCD spectroscopy even without the aid of DFT calculations’, and
this statement is clearly demonstrated herein. Nevertheless, it is
important to stress that despite the relative success of this ap-
proach, any assignment of absolute conﬁguration involving com-
parison of experimental VCD data only is highly dependent on
the correct absolute conﬁguration of the model compound.
Even though this is not the ﬁrst example of VCD spectral arith-
metic operations5,7 used to solve stereochemical problems, this
Figure 4. On the left: comparison of the observed VCD for 1with the average experimental VCD [(2S,1000R,2000R,4000S + 2R,1000R,2000R,4000S)/2] for the fenchol derivatives 2 and 3. On
the right: chemical structure and absolute conﬁguration of the novel diastereomeric mixture 1.
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uously the absolute conﬁguration of natural product molecules
with multiple chiral centers even in mixtures. Particularly for this
case, none of the classical approaches such as X-ray crystallogra-
phy, NMR, and electronic circular dichroism (ECD) could be used
to tackle this stereochemical challenge. In particular, ECD would
be of no value since for all the other monoterpene chromane esters
their ECD spectra were identical to that obtained for the chiral
chromane alone. Besides this fact, for the mixture described in this
work the chromane chromophore is racemic and, as expected,
yielded an null ECD spectrum.
Finally, the stereochemistry of the secondary metabolites pro-
vides some insights about their biosynthesis. From this work we
learn that P. obtusifolia biosynthesizes both enantiomers of the
chiral chromane and both enantiomers of fenchol, probably as
racemates, nevertheless attaches them stereoselectively. The pres-
ence of a racemic chromane may indicate the lack of enzymatic
control in the ﬁnal ring closure step, while racemic monoterpenes
may indicate two separate enzyme systems each capable of pro-
ducing a single enantiomer.8 Further biosynthetic and proteomic
studies on P. obtusifolia are under way.
Conclusion
Analysis of the IR and VCD spectra of an unresolved chiral chro-
matography peak allowed the assignment of its structure and
absolute conﬁguration, directly in solution, without derivatization,
and without the aid of further DFT calculations. Such a peak was
characterized as a diastereomeric mixture of two novel monoter-
pene chromane esters with (rac-2,1000S,2000S,4000R) absolute conﬁgura-
tion. It is also noteworthy that these two compounds are the
enantiomers of 2 and 3, both described earlier. This work expands
our knowledge about composition and stereochemistry of mono-terpene chromane esters within P. obtusifolia and provides another
example of how powerful and versatile vibrational optical activity
can be for the stereochemical analysis of complex chiral natural
product molecules even in mixtures.
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